The study of spermatogenesis in the horse is challenging because of the absence of an in vitro system that is capable of reproducing efficient spermatogenesis and because of the difficulties and costs associated with performing well-controlled studies in vivo. In an attempt to develop novel methods for the study of equine spermatogenesis, we tested whether cells from enzymatically digested pre-pubertal equine testicular tissue were capable of de novo tissue formation and spermatogenesis following xenografting under the back skin of immunocompromised mice. Testes were obtained from normal pre-pubertal colts and dissociated into cell suspensions using trypsin/collagenase digestion. Resulting cell pellets, consisting of both somatic and germ cells, were injected into fascial pockets under the back skin of immunocompromised, castrated mice and maintained for between 1 and 14 months. Mice were killed and grafts were recovered and analyzed. As has been reported for testis cell suspensions from pigs, mice, cattle, and sheep, de novo formation of equine testicular tissue was observed, as evidenced by the presence of seminiferous tubules and an interstitial compartment. There was an increased likelihood of de novo testicular formation as grafting period increased. Using indirect immunofluorescence, we confirmed the presence of spermatogonia in de novo formed seminiferous tubules. However, we found no evidence of meiotic or haploid cells. These results indicate that dissociated pre-pubertal equine testis cells are capable of reorganizing into the highly specialized endocrine and spermatogenic compartments of the testis following ectopic xenografting. However, in spite of the presence of spermatogonia within the seminiferous tubules, spermatogenesis does not occur. Although this technique does allow access to the cells within the seminiferous tubule and interstitial compartments of the equine testis prior to reaggregation, the absence of spermatogenesis will limit its use as a method for the study of testicular function in the horse.
INTRODUCTION
Normal spermatogenesis requires coordinated input from a variety of cell populations including germ cells, Sertoli cells, Leydig cells, and other somatic cells (Russell et al., 1990) . Additionally, an intricate network of paracrine and endocrine factors is involved. These complex cell associations and hormonal signaling pathways have contributed to the fact that full spermatogenesis (from diploid spermatogonia to highly differentiated, haploid spermatozoa), has so far only been reproduced in vitro from immature mouse testis, and has not been accomplished at all using equine germ cells (Stukenborg et al., 2009; Sato et al., 2011; Abu Elhija et al., 2012; Hunter et al., 2012; Hou et al., 2014) . Thus, researchers often must rely on in vivo experiments if they want to study the microenvironment of the testis.
Our laboratory studies testicular function in the domestic horse stallion (Equus caballus), a species in which genetically superior males are extremely valuable. Subfertility or infertility in these elite stallions can result in substantial genetic and economic losses. However, because of the relatively long delay in the onset of puberty, the large genetic variability, the lack of transgenic and knockout technologies, and the limited number of molecular tools that are available to study the equine system, the study of spermatogenesis in the horse is particularly challenging. Studies on equine spermatogenesis would be greatly facilitated by the development of an in vitro model system and/ or the development of a well-controlled in vivo system that preserves the complex cell-cell interactions of the testis while still allowing for manipulation of the testicular microenvironment.
Ideally, such a system also would not require extensive experimentation in live horses as these studies often are cost prohibitive as well as logistically and ethically unacceptable.
Over the past several years, small fragments of pre-pubertal and, with less success, adult testicular tissue from at least 23 different mammalian species including the horse have been shown to reconstitute spermatogenesis after ectopic xenografting to immunodeficient mouse hosts (reviewed in Arregui & Dobrinski, 2014) . The efficiency of spermatogenesis in the xenograft is highly species dependent, ranging from full spermatogenesis including the production of testicular spermatozoa, to incomplete, inefficient spermatogenesis that develops in only a percentage of seminiferous tubules. The pig falls into the former category, with meiotic cells present in over 90% of seminiferous tubules and haploid cells, including elongating spermatids capable of fertilization by intracytoplasmic sperm injection, present in approximately 45% of tubules (Honaramooz et al. 2002b) . The horse falls into the latter category. Equine pre-pubertal testicular xenografts produce very limited spermatogenesis with less than 10% of seminiferous tubules supporting the development of haploid cells . Fully formed testicular spermatozoa have not been reported in equine testis tissue xenografts to the best of our knowledge. Because spermatogenesis is present in only a small minority of tubules, and because even in those tubules, testicular spermatozoa are not observed, testis tissue xenografting has limited applications to the study of spermatogenesis in the equine. Nonetheless, it has been successfully used to study equine testicular disorders in which spermatogenesis is absent or very limited, such as cryptorchidism and agerelated testicular degeneration (Turner et al., , 2010 Turner & Zeng, 2012) .
Interestingly, isolated somatic cells from neonatal porcine testes are capable of reorganizing into testicular cords after transplantation under the kidney capsule of immunocompromised mice (Chakraborty, 1993; Dufour et al., 2002) . Taking this one step further, we showed previously that isolated neonatal porcine testis cells, including both somatic cells and germ cells, reaggregate into apparently complete, functional testicular tissue that supports full porcine spermatogenesis following ectopic grafting under the back skin of immunocompromised mice (Honaramooz et al., 2007) . Similar findings also were reported with isolated murine, bovine, and ovine testicular cells (Kita et al., 2007; Arregui et al., 2008a; Zhang et al., 2008) . This technique has been referred to as de novo morphogenesis of testicular tissue. Having the ability to access individual cell populations prior to their reaggregation into a testis could provide a new means to study and manipulate spermatogenesis. For example, the potential now exists to transfect specific cell populations prior to de novo testis formation. With that in mind, the objective of this study was to determine if ectopic xenografting of isolated pre-pubertal equine testis cells would result in de novo formation of functional testicular tissue capable of supporting equine spermatogenesis.
MATERIALS AND METHODS

Testicular tissue samples
Testicles were obtained from four pre-pubertal colts and one adult stallion following owner-elected castration. All castrations were performed under field conditions using injectable anesthesia as is standard for routine equine castrations. Two of the pre-pubertal donor animals were 7-month-old Thoroughbred colts. Tissue from these animals was stored in sterile saline at 4°C for 12 h prior to tissue digestion and xenografting. The remaining two pre-pubertal donor animals were 6-month and 1-year-old mixed breed colts. The adult animal was a 5-year-old mixed breed stallion. Tissue from these animals was stored in sterile saline at 4°C for 24 h prior to tissue digestion and/or xenografting. Small pieces of testicular tissue from each donor animal were fixed in Bouin's solution prior to tissue digestion to serve as a reference point for tissue condition at the time of cell isolation.
Tissue digestion
Pieces of testicular tissue (8-27 mm 3 ) from each of the four pre-pubertal colts were subjected to a two-step trypsin/collagenase enzymatic digestion as previously described (Bellve et al., 1977; Honaramooz et al., 2002a Honaramooz et al., , 2007 . After removal of the tunica albuginea, testicular tissue was submerged and dissociated in a solution of Dulbecco's modified Eagle medium (DMEM) containing 2 mg/mL collagenase Type IV (SigmaAldrich, St. Louis, MO, USA) at 37°C for 30 min in a shaking water bath. Hyaluronidase (1 mg/mL, Sigma-Aldrich) then was added and the samples were incubated for an additional 20 min with shaking. Tissue was then rinsed twice in Dulbecco's phosphate-buffered saline (DPBS) without calcium. Samples were incubated for an additional 10 min at 37°C in 0.25% (w/v) trypsin and 1 mM EDTA. If excessive cell clumping was observed, DNase I in DMEM (Sigma) was added to a final concentration of 0.1 mg/mL to achieve a more homogeneous cell suspension. Digestion was stopped by the addition of fetal bovine serum to a final concentration of 2% (v:v) . After enzymatic treatment, the resulting cells were filtered through 40-lm mesh (Tetko, Kansas City, MO, USA) to remove remaining cell clumps and obtain a cell suspension. The number of cells was quantitated using a Cellometer Auto T4 (Nexcelom Bioscience, Lawrence, MA, USA). Aliquots of 33-50 9 10 6 cells in DMEM then were concentrated by centrifugation at 1000 9 g for 5 min to obtain cell pellets. Cell pellets were maintained on ice while recipient mice were surgically prepared for immediate xenografting.
Grafting procedure
NCr SCID BALB/c mice were anesthetized and castrated. Linear incisions (0.5 mm) were made into the back skin, approximately 1 cm to the right or left of the spinal column between the shoulder and the rump. One incision was made for each pellet or graft to be transferred. A small pocket was made under each incision by blunt dissection into the subcutaneous fascia.
Depending on the available cell numbers, 2-5 cell pellets of collagenase/trypsin-digested pre-pubertal equine testicular tissue were aspirated into polyethylene tubing and transferred gently into a prepared fascial pocket on the right side of the recipient mouse (Honaramooz et al., 2007) . The skin incisions were closed with Michel wound clips (7.5 mm; Miltex, York, PA, USA). These grafts will be referred to as cell aggregate xenografts. Four to eight mouse recipients were used for each of the four pre-pubertal donors, also depending on the available cell numbers (total of 51 cell aggregate xenografts). At the same time, three or four standard 8-27 mm 3 tissue xenografts were placed into similar fascial pockets on the left side of each host mouse as previously described (total of 80 tissue xenografts; Honaramooz et al., 2002b) . For three of the pre-pubertal donors, both the cell aggregate and tissue xenografts were derived from the same donor's testicular tissue. For one pre-pubertal donor (the 6-month-old mixed breed colt), only the cell aggregate xenografts were derived from the donor's testicular tissue (four recipient mice carrying eight of the 51 cell aggregate xenografts), while the tissue xenografts were derived from testicular tissue from the 5-year-old adult stallion (adult tissue xenografts; 12 of the 80 tissue xenografts).
All work involving animals was conducted under ethical guidelines that were reviewed, approved, and monitored by the University of Pennsylvania's Institutional Animal Care and Use Committee.
Analysis of the grafted testes
The host mice were killed by CO 2 inhalation at 1-2-month intervals between 1 and 14 months post grafting. Specific time points were chosen based on the number of recipient mice available for each donor and with a goal of observing a reasonable time progression for the development of the xenografts. The skin tissue containing the grafts was dissected to isolate the grafts and each graft was weighed before being fixed in Bouin's solution overnight and processed for histology using hematoxylin and eosin staining.
Stained sections from each graft were examined histologically. Tissue xenografts were considered degenerate if either (i) the graft could not be identified and therefore was not recovered or (ii) if the recovered graft contained no seminiferous tubules. The number of degenerate tissue xenografts was divided by the total number of tissue xenografts originally placed to determine the percentage of degenerate tissue xenografts (Fig. 1A) .
Cell aggregate xenografts were considered degenerate if (i) the graft could not be identified and therefore was not recovered or (ii) if the recovered graft contained no seminiferous tubules and primarily consisted of fat or fibrous tissue. Non-degenerate cell aggregate xenografts then were placed into one of three categories based on histologic appearance: (I) cells organizing into sheets and whorls, but with no definitive histologic evidence of seminiferous tubules; and (II) cells organizing into sheets and whorls with scattered organization into early stages of seminiferous tubule; and (III) cells organizing into numerous, readily identifiable seminiferous tubules (Figs 1B and 3). The category of each cell aggregate xenograft was recorded and analyzed as a measure of the ability of the cell aggregate xenografts to develop into testicular tissue.
For tissue xenografts and Category III cell aggregate xenografts, 100 seminiferous tubule cross sections were examined. If <100 tubule cross sections were identified, then all were counted. Each tubule was classified as healthy (expanded tubule with normal cellular associations) or degenerate (collapsed tubule containing degenerate cells) and the percentage of healthy tubules per total tubules counted was calculated. For each healthy tubule, tubule cross sections were examined for evidence of spermatogenesis by determining the most advanced germ cell type present within the tubule (Fig. 1) .
Seminal vesicles from all recipient mice were weighed and used as an indirect bioassay for the secretion of bioactive testosterone by the xenografts. Because growth and development of the seminal vesicles are highly androgen-dependent processes, larger seminal vesicles indicate the presence of bioactive testosterone while smaller seminal vesicles indicate an absence of the hormone (Honaramooz et al., 2002b; Schlatt et al., 2003) . Because recipient mice are castrated at the time of xenograft placement, any bioactive testosterone is indicative of androgen production by the xenografts.
Indirect immunofluorescence
Alpha-SMA is a marker for peritubular myoid cells in the testis (Groshel-Stewart & Unsicker, 1977) . UCH-L1 (also referred to as PGP 9.5) is a spermatogonia-specific marker in both porcine and bovine testicular tissue (Luo et al., 2006; Herrid et al., 2007) . SYP3 is a synaptonemal complex protein used as a marker for meiotic cells (de la Fuente et al., 2007) . Cell aggregate xenografts that had formed seminiferous tubules were analyzed using indirect immunofluorescence for alpha-SMA, UCH-L1, and SYP3 to confirm the presence of seminiferous tubules, spermatogonia, and meiotic germ cells, respectively. Paraffin tissue sections were deparaffinized and hydrated using xylene and a series of solutions containing decreasing concentrations of ethanol. Slides then were incubated for 10-30 min in a warm antigen unmasking solution (Vector Laboratories, Burlingame, CA, USA), cooled, and rinsed three times in PBS.
For the UCH-L1 antibody, sections were incubated in 0.3% hydrogen peroxide in methanol for 30 min and rinsed again in PBS. Slides then were blocked for one hour at room temperature in 3% non-fat milk before being washed again in PBS. For the alpha-SMA and SYP3 antibodies, sections were blocked using CAS-Block (Invitrogen, Carlsbad, CA, USA) overnight at 4°C.
Tissue sections then were incubated in a rabbit anti-human alpha-SMA antibody (1:200 v:v dilution; EMD Millipore, Billerica, MA, USA, Catalog number MAB-T381), a rabbit anti-human UCH-L1 antibody (1:100 v:v dilution; Sigma-Aldrich, St. Louis, MO, USA, Catalog number HPA005993), or a rabbit anti-human SYP3 antibody (1:100 v:v dilution; Abcam, San Francisco, CA, Catalog number AB15093) in 10% goat serum for 1 h at room temperature or overnight at 4°C in a humid chamber. Slides were washed in PBS and incubated in the appropriate secondary antibody [UCH-L1: goat anti-rabbit, Alexa Fluor 488-conjugated secondary antibody; alpha-SMA and SYP3: mouse anti-rabbit, Alexa Fluor488-conjugated secondary antibody (all from ThermoFisher Scientific, Waltham, MA)] diluted to 5 lg/mL in 10% goat serum for 1 h at room temperature in a humid chamber, and washed for a final time in PBS. Controls were obtained using the same technique but with the primary antibody omitted to identify any background fluorescence and to rule out non-specific staining by the secondary antibody. Images were obtained using a fluorescent microscope (Leica Microsystem Bannockburn II) equipped with OPEN LAB software (Improvision, Lexington, MA, USA; Schlingmann et al., 2007) .
Statistical analysis
Robust mixed-effects linear regression models or (when indicated) robust linear regression models were used for analysis of all data. Values of p < 0.05 were considered significant.
RESULTS
Graft recovery and gross analysis
Graft recovery is summarized in Table 1 . Because all adult tissue xenografts were degenerate, these grafts were excluded from 338 Andrology, 2017, 5, 336-346 further statistical analysis. Weights of all non-degenerate grafts were recorded as an indicator of graft growth. The recipient mouse was a random effect factor that influenced graft weight. The mean (AESD) weight of all non-degenerate pre-pubertal tissue xenografts and cell aggregate xenografts regardless of grafting time is listed in Table 1 . After grafting times of approximately 1-2 months, pre-pubertal tissue xenografts weighed significantly more than cell aggregate xenografts (average of 19.3 mg heavier; p < 0.0001). However, pre-pubertal tissue xenografts and cell aggregate xenografts exhibited significantly different changes in weight over time (p < 0.0001).
The pre-pubertal tissue xenografts lost weight at a rate of approximately 0.65 mg per month while the cell aggregate xenografts gained weight at a rate of approximately 1.23 mg per month. As such, the average weights of the pre-pubertal tissue xenografts and cell aggregate xenografts were no longer significantly different after longer grafting times.
Seminal vesicle weight
Robust linear regression modeling was applied to the analysis of seminal vesicle weight. Seminal vesicle weight increased significantly in direct association with increasing graft weight, 
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suggesting that larger grafts produce more bioactive testosterone than smaller grafts (p = 0.019). For each 1 mg increase in graft weight, a 2.5 mg increase in seminal vesicle weight was observed. For mice carrying pre-pubertal tissue xenografts together with paired cell aggregate xenografts, the age of the donor horse did not significantly affect the weight of the seminal vesicles.
None of the four mice carrying adult tissue xenografts together with the cell aggregate xenografts had seminal vesicles that weighed >50 mg, indicating that neither the cell aggregate xenografts nor the adult tissue xenografts were producing bioactive testosterone in this small sample set (mean SV weight 27.5 AE 15 mg; Schlatt et al., 2003) . In contrast, in 76% of mice carrying prepubertal tissue xenografts together with cell aggregate xenografts, the weights of the seminal vesicles were well over 50 mg (242.9 AE 70.3 mg), indicating that the cell aggregate xenografts and/or the pre-pubertal tissue xenografts carried by these mice were producing bioactive testosterone.
Spermatogenesis within the pre-pubertal tissue xenografts
For non-degenerate pre-pubertal tissue xenografts, seminiferous tubules were counted and classified as degenerate or healthy. If a tubule was healthy, the most advanced germ cell stage present within that tubule was recorded and analyzed as a measure of graft function (i.e. as a measure of whether or not the graft supported spermatogenesis; n = 4605 tubules). After 1-4 months of grafting time, 0% of the tubules from pre-pubertal tissue xenografts were degenerate, 32% contained only Sertoli cells, and 68% contained spermatogonia. Three percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. After 5-6-month grafting periods, <1% of the tubules from pre-pubertal tissue xenografts were degenerate, 30% contained only Sertoli cells, and 69% contained spermatogonia. Four percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. After grafting periods of 7-8 months, 6% of the tubules from pre-pubertal tissue xenografts were degenerate, 39% contained only Sertoli cells, and 55% contained spermatogonia. Three percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. After longer grafting periods of 9-14 months, 3% of the tubules from pre-pubertal tissue xenografts were degenerate, 24% contained only Sertoli cells, and 73% contained spermatogonia. Two percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. However, in all cases, the histologic appearance of these cells was not considered to be sufficient proof of the presence of pachytene spermatocytes (Fig. 3D,F) . Haploid cells were not identified in any of the tissue grafts (Fig. 2A) .
The percentage of seminiferous tubules in the pre-pubertal tissue xenografts containing only Sertoli cells or Sertoli cells with spermatogonia did not change significantly with increased grafting periods. Reorganization of seminiferous tubules in cell aggregate xenografts In most cases, healthy cell aggregate xenografts could be readily placed into one of the three categories: (I) cells organizing into sheets and whorls, but with no definitive histologic evidence of seminiferous tubule formation (Fig. 3A) ; (II) cells organizing into sheets and whorls with scattered organization into early stages of seminiferous tubule formation (Fig. 3B) ; and (III) cells organizing into numerous, readily identifiable seminiferous tubules (Fig. 3C) . The category of each cell aggregate xenograft was recorded and analyzed as a measure of the ability of the cell aggregate xenografts to reorganize into testicular tissue.
Forty-two percent of the healthy cell aggregate xenografts recovered after 1-4-month graft periods were placed in Category I. This decreased to 28% after 5-6-month graft periods, and 0% after 7-8-month and 9-14-month graft periods. Fifty-eight percent of the healthy cell aggregate xenografts recovered after 1-4-month graft periods were placed in Category II. After 5-6-month graft periods, 57% were placed in Category II. After 7-8-month and 9-14-month graft periods, 45% and 43%, respectively, were placed in Category II . None of the healthy cell aggregate xenografts recovered after 1-4-month graft periods were placed in Category III. This increased to 14% after 5-6-month graft periods, 55% after 7-8-month graft periods, and 57% after 9-14-month graft periods. As graft period length increased, it was significantly more likely that grafts would be found in the higher categories. There was a 44% increase in likelihood that a graft would be placed in Category II or III for each 1-month increase in graft period (p = 0.001). Grafts maintained for 9 months or longer had a 13-fold increase in the odds of being in Category II or III compared to grafts maintained for 4 months or less.
For aggregate grafts that were placed in Category III, seminiferous tubules were counted and the most advanced germ cell type present within each tubule was recorded (n = 261 tubules). After 5-6-month graft periods, 30% of the tubules in Category III cell aggregate xenografts contained only Sertoli cells, and 70% contained spermatogonia as the most advanced germ cell stage. No tubules contained multiple layers of germ cells. After 7-8-month graft periods, 31% of the tubules in Category III cell aggregate xenografts contained only Sertoli cells, and 69% contained spermatogonia as the most advanced germ cell stage. Two percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. Six percent of the tubules in Category III cell aggregate xenografts recovered after 9-14-month graft periods contained only Sertoli cells and 94% contained spermatogonia as the most advanced germ cell stage. Three percent of the tubules that contained spermatogonia appeared to have multiple layers of germ cells and included some cells histologically similar to pachytene spermatocytes. However, in all cases, the histologic appearance of these cells was not considered to be sufficient proof of the presence of pachytene spermatocytes (Fig. 3D,F ). An absence of meiotic cells within these tubules was later confirmed using the SYP3 antibody (see below). Haploid cells were not identified in any of the Category III cell aggregate xenografts (Fig. 2B) .
Similar to our observations of the pre-pubertal tissue xenografts, the percentage of tubules in the Category III cell aggregate xenografts containing only Sertoli cells or Sertoli cells with spermatogonia did not change significantly with increased grafting periods.
Finally, there were no significant differences between the prepubertal tissue xenografts and the Category III cell aggregate xenografts in the percentages of tubules supporting only Sertoli cells or supporting spermatogonia with or without multiple layers of germ cells.
Immunofluorescent identification of spermatogonia, but not meiotic cells, within seminiferous tubules in category III cell aggregate xenografts
To provide further evidence that the cell aggregates had reorganized into morphologically normal testicular tissue, we used the anti-SMA antibody for indirect immunofluorescence. In other mammalian species, myoid cells organize into either a single or multilayered ring around the outside of the basement membrane of the seminiferous tubules, thus defining the outline of each tubule (Maekawa et al., 1996) . In normal adult equine testes, we identified a single layer of myoid cells in the interstitium surrounding the basement membrane of each seminiferous tubule. This same pattern of immunofluorescence was identified surrounding each putative seminiferous tubule in our Category III cell aggregate xenografts, consistent with the formation of morphologically normal testicular tissue (Fig. 4) .
To confirm the presence of spermatogonia within Category III cell aggregate xenograft seminiferous tubules, we used the UCH-L1 antibody for indirect immunofluorescence. Immunofluorescence was present in cells along the basement membrane in the majority of seminiferous tubules from a representative Category III cell aggregate xenograft, similar to the appearance of UCH-L1 immunofluorescence seen in normal pre-pubertal testis tissue. This was consistent with the results of our analysis of the stained cell aggregate xenografts and confirmed that these de novo formed tubules contain spermatogonia (Fig. 5) .
Because histological identification of meiotic cells can be problematic, particularly when later stages of germ cells are absent, we performed indirect immunofluorescence using the anti-SYP3 antibody to determine whether or not Category III cell aggregate xenografts supported early spermatogenesis. We selected tissue from those cell aggregate xenografts that contained spermatogonia and that, based on hematoxylin and eosin staining, appeared to have multiple layers of germ cells including some cells histologically similar to pachytene spermatocytes (i.e. those samples that were deemed most likely to be supporting early spermatogenesis). As expected, numerous meiotic cells were identified by immunofluorescence within seminiferous tubules from testicular tissue from a normal adult stallion. However, meiotic cells were not identified within the cell aggregate xenografts, based on an absence of immunofluorescence (Fig. 6) .
DISCUSSION
In the porcine system, xenografting of dissociated cells from pre-pubertal testes resulted in de novo formation of histologically and functionally normal testicular tissue (Honaramooz et al., 2007) . Although dissociated cells from pre-pubertal equine testes did result in de novo formation of seminiferous tubules, particularly after longer grafting periods, we detected no definitive evidence of spermatogenesis in spite of the presence of numerous gonocytes/spermatogonia. This is consistent with previous work that showed that the limited spermatogenesis seen in some de novo formed xenografts was not because of a scarcity of germ cells (Dores & Dobrinski, 2014) .
We observed an apparent absence of spermatogenesis within the Category III cell aggregate xenografts and within pre-pubertal tissue xenografts maintained for comparable periods of time. In previous studies, we identified limited evidence of meiosis in tissue xenografts from both cryptorchid and normal, pre-pubertal equine testicular tissue. However, similar to this study, full spermatogenesis was never observed Turner et al., 2010) . In our previous studies, we noticed significant differences in the ability of testicular tissue from different age-matched donors to survive and develop as xenografts. Taken together, these findings suggest that undefined individual donor factors likely contribute to the success of xenograft development.
It is interesting to note that, in those species in which both tissue xenografts and cell aggregate xenografts have been described, the amount of spermatogenesis observed within the two different types of grafts is consistently similar. For example, in pigs, sheep, and rodents, a percentage of seminiferous tubules in both testicular tissue xenografts and testicular cell aggregate xenografts support full spermatogenesis and produce functional testicular spermatozoa (Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008a) . In contrast, in cattle and horses, neither testicular tissue xenografts nor testicular cell aggregate xenografts typically support spermatogenesis beyond the 342 Andrology, 2017, 5, 336-346 pachytene spermatocyte stage. It therefore seems likely that the factors responsible for inefficient spermatogenesis in the bovine and equine tissue xenografts are similarly responsible for the absence of or limited spermatogenesis observed in the cell aggregate xenografts. Additionally, one might predict that complete spermatogenesis will be observed only in cell aggregate grafts from those species for which full spermatogenesis has been demonstrated in tissue xenografts. These observations prompt us to question the causes of inefficient spermatogenesis in the testis tissue and cell aggregate xenografts from species like the equine and the bovine. Aberrant production of testosterone by the xenografts, species-specific differences in murine gonadotropins, hypoxic cell damage in the grafted tissue, and an inability to thermoregulate the grafted tissue, all have been proposed as possible contributing factors (Arregui & Dobrinski, 2014) . Many of these mechanisms have been explored, but have resulted in limited or no improvement in xenograft development and function.
Neither modulation of testosterone production from the xenografts nor supplementation of testosterone from fully functional testicular tissue has resulted in full spermatogenesis in xenografts from bulls or stallions, respectively (Turner et al., 2010; Rodriguez-Sosa et al., 2012) . Similarly, although supplementation of host mice with exogenous gonadotropins did enhance spermatogenesis in equine testis xenografts, it did not restore spermatogenesis to levels seen in testicular tissue in situ .
Transient hypoxia at the time of grafting is believed to contribute to inefficient xenograft development. In particular, metabolically active adult testicular tissue supporting full spermatogenesis at the time of grafting may be particularly sensitive to hypoxic damage, thus accounting for the high percentage of degeneration seen in adult testis xenografts Arregui et al., 2008b ; and current study). Graft survival is higher for pre-pubertal xenografts that lack spermatogenesis (and presumably are less metabolically active) at the time of grafting. Similarly, suppression of spermatogenesis in adult testicular tissue prior to xenografting improves xenograft survival (Arregui et al., 2012) .
In this study, there may have been an increased risk for hypoxic cell damage, as donor tissue was stored at 4°C for 12-24 h prior to tissue digestion and xenografting. Although cooled storage of porcine testes for up to 48 h had no adverse effect on the survival or development of subsequent xenografts (Honaramooz et al., 2002b) , equine tissue may sustain more damage during cooling and this could contribute to the limited development of our equine xenografts.
We have attempted to improve vascularization of testis xenografts to minimize hypoxic damage. Although the addition of vascular endothelial growth factor 165, an angiogenic factor, did increase the number of tubules containing gonocytes, angiogenesis was not improved, and therefore, the issue of hypoxia as a contributing factor to inefficient graft development could not be determined (Dores & Dobrinski, 2014) . Interestingly, in this same report, the addition of extracellular matrix components to cell aggregate xenografts did improve spermatogenic efficiency, probably by providing a scaffold for the dissociated cells and by maintaining the cells in closer proximity to one another.
As maintenance of an appropriate testicular temperature is required for normal spermatogenesis, the testis has developed methods for thermoregulation. These include the cremaster muscle, the pampiniform plexus, the tunica dartos muscle, and sweat glands in the scrotal skin (reviewed in Shafik, 1991) . Testis xenografts, similar to abdominally cryptorchid testes, have none of these mechanisms and this is likely to adversely impact spermatogenesis (Turner et al., 2010) . Future studies designed to 344 Andrology, 2017, 5, 336-346 improve the ability of testis xenografts to thermoregulate could result in improved spermatogenesis.
Spermatogenic efficiency similar to that observed in bovine and equine xenografts has been described in testis xenografts from human infant and pre-pubertal boys. In these immature human testis xenografts, spermatogenesis either did not occur at all, or when it did occur, rarely progressed beyond the pachytene spermatocyte stage (Goossens et al., 2008; Sato et al., 2010) . Further study on the causes for limited development of equine xenografts could contribute to improvements in development of human xenografts, thus allowing xenografting to be used for the preservation of genetic material in, for example, pre-pubertal boys undergoing gonadotoxic treatment or in boys with testicular cancer (Orwig & Schlatt, 2005) .
Because recipient mice are castrated at the time of xenografting, any testosterone produced after grafting must originate from the xenografted testicular tissue. None of the mice carrying nondegenerate cell aggregate xenografts together with degenerate tissue grafts were exposed to bioactive testosterone based on the weights of the seminal vesicles. In comparison, the majority of mice carrying non-degenerate cell aggregate xenografts together with non-degenerate tissue xenografts were exposed to bioactive testosterone from the grafts based on the weights of the seminal vesicles. We therefore have no direct evidence that our equine cell aggregate xenografts produced bioactive testosterone, independent of the tissue xenografts. This was unexpected as we have previously shown that mice carrying only cell aggregate xenografts from neonatal porcine testes typically have large, well-developed seminal vesicles (Honaramooz et al., 2007; Dores & Dobrinski, 2014) . Studies on androgen receptor knockout (ARKO) mice have shown that androgens are not required for formation of the testes. In fact, histological examination of the testes of ARKO mice revealed a phenotype similar to our equine xenografts. Specifically, seminiferous tubules were present, but spermatogenesis was arrested at the pachytene stage (Yeh et al., 2002) . It is therefore possible that equine cell aggregate xenografts could develop into seminiferous tubules supporting limited spermatogenesis, even in the absence of testosterone.
In conclusion, as was reported in pigs, sheep, cattle, and rodents, whole-cell suspensions of digested pre-pubertal equine testicular tissue are capable of de novo morphogenesis into the highly specialized spermatogenic compartments of the testis after xenografting onto immunocompromised mice. However, equine testis tissue digests did not reconstitute spermatogenesis, similar to observations in equine pre-pubertal testis tissue xenografts. The absence of spermatogenesis in equine aggregate grafts will limit the utility of this technique for the study of spermatogenesis in the horse.
